TRLV logo

TRLV Trulieve Cannabis Corp.

New York Stock Exchange · Drug Manufacturers - Specialty & Generic · Healthcare

$9.35
-0.67 (-6.69%)

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, F…

Market Cap: $1.59Bwww.trulieve.com

Price

No data yet.

Social Signal Score

42
5d
—
30d
43
3 mentions
—
60d
38
5 mentions
—
90d
44
6 mentions
—
news: 6

Analyst Ratings

1 analyst
Buyconsensus
Strong Buy 0Buy 1Hold 0Sell 0Strong Sell 0
Avg price target$15+60.4%
Low $15Median $15High $15
Current Consensus

Revenue

$230.22M-23.79%
$230.22M$254.17M$278.13M$302.09M
Jun 2025Sep 2026

Analyst Estimates

FY2025
$-0.43
$-0.44–$-0.42
2 analysts
FY2026
$-2.02
$-2.08–$-1.93
4 analysts
FY2027
$0.35
$0.08–$0.56
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Kimberly A. Rivers
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5,000
Beta
1.92
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
0.24
www.trulieve.com